Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

NKTX

Nkarta (NKTX)

Nkarta Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NKTX
FechaHoraFuenteTítuloSímboloCompañía
25/07/202215:31GlobeNewswire Inc.Nkarta Announces Key Senior Leadership Team AppointmentsNASDAQ:NKTXNkarta Inc
18/07/202217:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NKTXNkarta Inc
10/06/202215:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NKTXNkarta Inc
03/06/202212:35Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NKTXNkarta Inc
31/05/202206:02GlobeNewswire Inc.Nkarta to Participate at Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
24/05/202203:12TipRanksMizuho Securities Sticks to Their Buy Rating for Nkarta (NKTX)NASDAQ:NKTXNkarta Inc
16/05/202215:02GlobeNewswire Inc.Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentNASDAQ:NKTXNkarta Inc
15/05/202221:06TipRanksNkarta (NKTX) Receives a Buy from Stifel NicolausNASDAQ:NKTXNkarta Inc
13/05/202205:15TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:NKTXNkarta Inc
12/05/202215:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NKTXNkarta Inc
12/05/202215:02GlobeNewswire Inc.Nkarta Reports First Quarter 2022 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
28/04/202215:01GlobeNewswire Inc.Nkarta Announces Closing of Upsized Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional SharesNASDAQ:NKTXNkarta Inc
25/04/202222:19GlobeNewswire Inc.Nkarta Announces Pricing of Upsized Public Offering of Common StockNASDAQ:NKTXNkarta Inc
25/04/202215:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NKTXNkarta Inc
25/04/202215:01GlobeNewswire Inc.Nkarta Announces Proposed Public Offering of Common StockNASDAQ:NKTXNkarta Inc
25/04/202207:25TipRanksMizuho Securities Keeps Their Buy Rating on Nkarta (NKTX)NASDAQ:NKTXNkarta Inc
25/04/202206:00GlobeNewswire Inc.Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell ProgramsNASDAQ:NKTXNkarta Inc
22/04/202215:10GlobeNewswire Inc.Nkarta to Host Conference Call Highlighting Preliminary Clinical Data from Two Lead NK Cell Therapy CandidatesNASDAQ:NKTXNkarta Inc
21/04/202215:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NKTXNkarta Inc
08/04/202212:25GlobeNewswire Inc.Nkarta Presents New Preclinical Data from Engineered NK Cell Platform at AACR Annual Meeting 2022NASDAQ:NKTXNkarta Inc
29/03/202215:10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NKTXNkarta Inc
29/03/202207:02GlobeNewswire Inc.Nkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of DirectorsNASDAQ:NKTXNkarta Inc
22/03/202209:05TipRanksAnalysts Offer Insights on Healthcare Companies: Align Tech (ALGN) and Nkarta (NKTX)NASDAQ:NKTXNkarta Inc
17/03/202218:35TipRanksMizuho Securities Thinks Nkarta’s Stock is Going to RecoverNASDAQ:NKTXNkarta Inc
17/03/202215:50Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NKTXNkarta Inc
17/03/202215:23Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NKTXNkarta Inc
17/03/202215:02GlobeNewswire Inc.Nkarta Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
08/03/202215:35GlobeNewswire Inc.Nkarta to Present Preclinical Data from Engineered NK Cell Platform at the American Association for Cancer Research 2022 Annual MeetingNASDAQ:NKTXNkarta Inc
08/03/202205:16TipRanksNkarta (NKTX) Gets a Buy Rating from H.C. WainwrightNASDAQ:NKTXNkarta Inc
18/02/202215:16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NKTXNkarta Inc
 Showing the most relevant articles for your search:NASDAQ:NKTX

Su Consulta Reciente

Delayed Upgrade Clock